Belluscura

Belluscura is a medical device company focused on oxygen-based treatment platforms. It develops and licenses technologies that can be applied across a range of respiratory care applications, including chronic lung diseases, and seeks to deliver portable, adaptable solutions. Its first product, X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger tanks, with a modular approach to enable broader use. The company operates in the United States through the sale of oxygen concentrators and maintains a diversified portfolio of patents and applications—approximately 26—covering oxygen enrichment devices and related treatments. Founded in 2015, Belluscura is based in London, United Kingdom, and pursues opportunities both in the UK and internationally.